The kinome-wide RNAi screen identified WEE1 as a key mediator of ABT-199 resistance in BC, with WEE1 inhibition significantly enhancing sensitivity to BCL-2 inhibitors [146]. The gene discussed is WEE1; the disease is breast cancer.